Mahnaz Asgharnejad
Takeda (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Migraine and Headache Studies, Epilepsy research and treatment, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents(2000)280 cited
- → ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease(2017)148 cited
- → Sumatriptan nasal spray for the acute treatment of migraine(1997)139 cited
- → Naratriptan is effective and well tolerated in the acute treatment of migraine(1997)132 cited
- → Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine. Results of a Double‐Blind, Placebo‐Controlled, Parallel‐Group Study(1997)112 cited
- → A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain(2015)107 cited
- → Subcutaneous Sumatriptan for Treatment of Acute Migraine in Patients Admitted to the Emergency Department: A Multicenter Study(1995)104 cited
- → Comparing the Incidence of Falls/Fractures in Parkinson’s Disease Patients in the US Population(2016)84 cited
- → A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)(2022)74 cited
- → The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial(2023)71 cited